These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15761117)

  • 1. Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis.
    Lagane B; Ballet S; Planchenault T; Balabanian K; Le Poul E; Blanpain C; Percherancier Y; Staropoli I; Vassart G; Oppermann M; Parmentier M; Bachelerie F
    Mol Pharmacol; 2005 Jun; 67(6):1966-76. PubMed ID: 15761117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif.
    Huttenrauch F; Nitzki A; Lin FT; Höning S; Oppermann M
    J Biol Chem; 2002 Aug; 277(34):30769-77. PubMed ID: 12065593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.
    Hüttenrauch F; Pollok-Kopp B; Oppermann M
    J Biol Chem; 2005 Nov; 280(45):37503-15. PubMed ID: 16144840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor CCR5: insights into structure, function, and regulation.
    Oppermann M
    Cell Signal; 2004 Nov; 16(11):1201-10. PubMed ID: 15337520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional consequences of chemically-induced β-arrestin binding to chemokine receptors CXCR4 and CCR5 in the absence of ligand stimulation.
    Liebick M; Henze S; Vogt V; Oppermann M
    Cell Signal; 2017 Oct; 38():201-211. PubMed ID: 28733085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
    Estall JL; Koehler JA; Yusta B; Drucker DJ
    J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylation of the 5-hydroxytryptamine4a receptor regulates receptor phosphorylation, desensitization, and beta-arrestin-mediated endocytosis.
    Ponimaskin E; Dumuis A; Gaven F; Barthet G; Heine M; Glebov K; Richter DW; Oppermann M
    Mol Pharmacol; 2005 May; 67(5):1434-43. PubMed ID: 15689570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization.
    Kraft K; Olbrich H; Majoul I; Mack M; Proudfoot A; Oppermann M
    J Biol Chem; 2001 Sep; 276(37):34408-18. PubMed ID: 11448957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates.
    Amara A; Vidy A; Boulla G; Mollier K; Garcia-Perez J; Alcamí J; Blanpain C; Parmentier M; Virelizier JL; Charneau P; Arenzana-Seisdedos F
    J Virol; 2003 Feb; 77(4):2550-8. PubMed ID: 12551993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
    Gripentrog JM; Miettinen HM
    Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor.
    Aramori I; Ferguson SS; Bieniasz PD; Zhang J; Cullen B; Cullen MG
    EMBO J; 1997 Aug; 16(15):4606-16. PubMed ID: 9303305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insight into the binding complex: β-arrestin/CCR5 complex.
    Stambouli N; Dridi M; Wei NN; Jlizi A; Bouraoui A; Elgaaied AB
    J Biomol Struct Dyn; 2014; 32(6):866-75. PubMed ID: 24404772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entry.
    Jin J; Colin P; Staropoli I; Lima-Fernandes E; Ferret C; Demir A; Rogée S; Hartley O; Randriamampita C; Scott MG; Marullo S; Sauvonnet N; Arenzana-Seisdedos F; Lagane B; Brelot A
    J Biol Chem; 2014 Jul; 289(27):19042-52. PubMed ID: 24855645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 3',5'-monophosphate signaling by beta-arrestin2.
    Ferrari SL; Bisello A
    Mol Endocrinol; 2001 Jan; 15(1):149-63. PubMed ID: 11145746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.
    Ferguson SS
    Pharmacol Rev; 2001 Mar; 53(1):1-24. PubMed ID: 11171937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into a novel human CCR5-V130I variant associated with resistance to HIV-1 infection.
    Stambouli N; Wei NN; Jlizi A; Aissa S; Abdelmalek R; Kilani B; Slim A; Tiouiri BA; Dridi M; Hamza A; Ben Ammar Elgaied A
    J Biomol Struct Dyn; 2014; 32(8):1202-10. PubMed ID: 23869485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
    Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
    J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of corticotropin-releasing hormone receptor type 1alpha signaling: structural determinants for G protein-coupled receptor kinase-mediated phosphorylation and agonist-mediated desensitization.
    Teli T; Markovic D; Levine MA; Hillhouse EW; Grammatopoulos DK
    Mol Endocrinol; 2005 Feb; 19(2):474-90. PubMed ID: 15498832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.
    Stanasila L; Abuin L; Dey J; Cotecchia S
    Mol Pharmacol; 2008 Sep; 74(3):562-73. PubMed ID: 18523139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.